Insider Insights
06.12.2022
France – Clinical trials: an improved 2021 but t...

France have improved the conduction of clinical trials in 2021, due to the reduction of regulatory d...

Read more
Insider Insights
06.12.2022
UK NHS England set to eliminate hepatitis C by 203...

NHS England has reported that following a 5-year £1b antiviral drugs deal, deaths from Hepatitis C ...

Read more
Articles
30.11.2022
Reflecting on the Pricing & Market Access tre...

Our experts reflect on the trends that shaped the European pricing and market access landscape in 20...

Read more
Newsletter
16.11.2022
PMA Insights: Week 46 SPECIAL EDITION ISPOR 2022 R...

We summarise the ISPOR Europe 2022 conference including plenary sessions on HTA, patient-centered re...

Read more
Publications
09.11.2022
ISPOR 2022 Plenary Session 3 - Integrating Data

Our experts provide a detailed summary of Plenary Session 2 at ISPOR 2022 on innovative methods for ...

Read more
Publications
08.11.2022
ISPOR 2022 Plenary Session 2 - Real-World Research

Our experts provide a detailed summary of Plenary Session 2 at ISPOR 2022 on real-world patient-cent...

Read more
Publications
07.11.2022
ISPOR 2022 Plenary Session 1 - HTA and Regulation

Our experts provide a detailed summary of Plenary Session 1 at ISPOR 2022 on the Convergence of HTA ...

Read more
News
02.11.2022
PMA Insights: Week 44

We summarise four handpicked articles from pharmaceutical, pricing and market access that are worth ...

Read more
Insider Insights
27.10.2022
France: Biologists take strike action against PLFS...

The Article outlined in the PLFSS requires laboratories to lower the prices of their routine examina...

Read more
Insider Insights
27.10.2022
Financial Stabilisation Act is passed, sparks crit...

This law is projected to have a large impact on the pharmaceutical industry and pharmacies nationwid...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.